Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 5,264 shares at $86.53 ($463K) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Open-market sale of $463k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.53 | 641 | $55K | 12.0% |
| 2 | $86.53 | 641 | $55K | 12.0% |
| 3 | $87.09 | 200 | $17K | 3.8% |
| 4 | $87.10 | 200 | $17K | 3.8% |
| 5 | $88.36 | 100 | $9K | 1.9% |
| 6 | $90.07 | 500 |
| $45K |
| 9.7% |
| 7 | $90.45 | 100 | $9K | 2.0% |
| 8 | $86.30 | 446 | $38K | 8.3% |
| 9 | $86.30 | 446 | $38K | 8.3% |
| 10 | $87.96 | 200 | $18K | 3.8% |
| 11 | $89.23 | 695 | $62K | 13.4% |
| 12 | $89.23 | 695 | $62K | 13.4% |
| 13 | $89.86 | 200 | $18K | 3.9% |
| 14 | $89.87 | 200 | $18K | 3.9% |
| Total | $88.00 avg | 5,264 | $463K | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |
| LOXO | SELL | 2018-10-05 | $2.0M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $2.8M | — | Filing → |